BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24839450)

  • 1. Protein Kinase Signaling at the Crossroads of Myocyte Life and Death in Ischemic Heart Disease.
    Vagnozzi RJ; Hoffman NE; Elrod JW; Madesh M; Force T
    Drug Discov Today Ther Strateg; 2012; 9(4):e173-e182. PubMed ID: 24839450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening.
    Xu T; Ding W; Ao X; Chu X; Wan Q; Wang Y; Xiao D; Yu W; Li M; Yu F; Wang J
    Redox Biol; 2019 Jan; 20():414-426. PubMed ID: 30415165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.
    Chen Q; Xu H; Xu A; Ross T; Bowler E; Hu Y; Lesnefsky EJ
    PLoS One; 2015; 10(3):e0118834. PubMed ID: 25756500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury.
    Ong SB; Samangouei P; Kalkhoran SB; Hausenloy DJ
    J Mol Cell Cardiol; 2015 Jan; 78():23-34. PubMed ID: 25446182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkin Regulates Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury by Targeting Cyclophilin-D.
    Sun T; Ding W; Xu T; Ao X; Yu T; Li M; Liu Y; Zhang X; Hou L; Wang J
    Antioxid Redox Signal; 2019 Dec; 31(16):1177-1193. PubMed ID: 31456416
    [No Abstract]   [Full Text] [Related]  

  • 6. Slow calcium waves and redox changes precede mitochondrial permeability transition pore opening in the intact heart during hypoxia and reoxygenation.
    Davidson SM; Yellon DM; Murphy MP; Duchen MR
    Cardiovasc Res; 2012 Mar; 93(3):445-53. PubMed ID: 22198507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes.
    Abdallah Y; Kasseckert SA; Iraqi W; Said M; Shahzad T; Erdogan A; Neuhof C; Gündüz D; Schlüter KD; Tillmanns H; Piper HM; Reusch HP; Ladilov Y
    J Cell Mol Med; 2011 Nov; 15(11):2478-85. PubMed ID: 21199327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis.
    Miura T; Tanno M; Sato T
    Cardiovasc Res; 2010 Oct; 88(1):7-15. PubMed ID: 20562423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3beta, a therapeutic target for cardiomyocyte protection.
    Miura T; Miki T
    Circ J; 2009 Jul; 73(7):1184-92. PubMed ID: 19506320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
    Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
    Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart.
    Vagnozzi RJ; Gatto GJ; Kallander LS; Hoffman NE; Mallilankaraman K; Ballard VL; Lawhorn BG; Stoy P; Philp J; Graves AP; Naito Y; Lepore JJ; Gao E; Madesh M; Force T
    Sci Transl Med; 2013 Oct; 5(207):207ra141. PubMed ID: 24132636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening.
    Wang S; Zhang F; Zhao G; Cheng Y; Wu T; Wu B; Zhang YE
    J Cell Mol Med; 2017 Sep; 21(9):2009-2021. PubMed ID: 28266127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury.
    Argaud L; Gomez L; Gateau-Roesch O; Couture-Lepetit E; Loufouat J; Robert D; Ovize M
    J Mol Cell Cardiol; 2005 Dec; 39(6):893-9. PubMed ID: 16243351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAX-1 regulates cyclophilin-D levels and mitochondria permeability transition pore in the heart.
    Lam CK; Zhao W; Liu GS; Cai WF; Gardner G; Adly G; Kranias EG
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6466-75. PubMed ID: 26553996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Sun Y; Zhang Y; Yan M; Wu Y; Zheng X
    Biol Pharm Bull; 2009 Sep; 32(9):1545-51. PubMed ID: 19721230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the mitochondrial permeability transition: cardiac ischemia-reperfusion versus carcinogenesis.
    Javadov S; Hunter JC; Barreto-Torres G; Parodi-Rullan R
    Cell Physiol Biochem; 2011; 27(3-4):179-90. PubMed ID: 21471706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.
    Miura T; Tanno M
    Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CaMKII determines mitochondrial stress responses in heart.
    Joiner ML; Koval OM; Li J; He BJ; Allamargot C; Gao Z; Luczak ED; Hall DD; Fink BD; Chen B; Yang J; Moore SA; Scholz TD; Strack S; Mohler PJ; Sivitz WI; Song LS; Anderson ME
    Nature; 2012 Nov; 491(7423):269-73. PubMed ID: 23051746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
    Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
    Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.